Sildenafil Tablet
Product Images NDC 76282-645

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 76282-645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sildenafil 1)

Chemical structure of sildenafil, showing its molecular arrangement and functional groups clearly depicted in a standard chemical formula diagram.*

FDA Label Image

Principal Display Panel -2 (Sildenafil 10)

Label for Sildenafil Tablets, USP 50 mg by Exelan Pharmaceuticals, Inc. The label includes storage instructions, dosage and use notes, and the NDC 76282-644-30. It indicates 30 tablets per container, with manufacturing by Appco Pharma LLC, Piscataway, NJ. A barcode and revision date 04/2022 are also shown.*

FDA Label Image

Principal Display Panel -3 (Sildenafil 11)

Label for Sildenafil Tablets, USP 50 mg oral tablets, distributed by Exelan Pharmaceuticals, Inc. The label includes storage instructions, dosage information, manufacturer details, and a barcode. The package contains 100 tablets and indicates prescription-only status.*

FDA Label Image

Principal Display Panel -4 (Sildenafil 12)

Label for Sildenafil Tablets, USP 100 mg oral tablets by Exelan Pharmaceuticals, Inc. The label states Rx only and a count of 30 tablets. Storage instructions note controlled room temperature at 25°C (77°F) with permitted excursions. Manufacturer is Appco Pharma LLC, Piscataway, NJ. The label includes a barcode and the NDC number 76282-645-30.*

FDA Label Image

Principal Display Panel -5 (Sildenafil 13)

Label for Sildenafil Tablets USP 100 mg oral tablets. The label shows the product name, strength (100 mg), packaging of 100 tablets, and the labeler Exelan Pharmaceuticals, Inc. It includes storage instructions, dispensing information, and manufacturer details (Appco Pharma LLC). The barcode and revision date are also visible.*

FDA Label Image

Figure 2 (Sildenafil 2)

A line graph showing systolic blood pressure changes (mmHg) over 24 hours post dose for Sildenafil 100 mg and placebo. The x-axis represents time in hours after dosing, and the y-axis shows systolic blood pressure values. Two lines compare the blood pressure trends between the Sildenafil 100 mg dose and placebo groups.*

FDA Label Image

Figure 3 (Sildenafil 3)

A line graph depicting change in systolic blood pressure (SBP) over time postdose in hours, comparing Doxazosin + Placebo with Doxazosin + Sildenafil 25 mg. The y-axis shows change in SBP (mmHg), and the x-axis shows time in hours postdose up to 8 hours. Two lines represent the comparative trends of blood pressure changes for the two treatment groups.*

FDA Label Image

Figure 4 (Sildenafil 4)

A line graph showing the change in EDP (mmHG) over time (hours) postdose for two treatment groups: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg. The x-axis represents time from 0 to 8 hours postdose, and the y-axis shows change in EDP with values ranging from -50 to 40 mmHG. Two curves illustrate the effect of the different treatments on EDP over time.*

FDA Label Image

Figure 5 (Sildenafil 5)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' over 8 hours after dosing. It compares the effects of Doxazosin with Sildenafil 100 mg and Doxazosin with placebo, showing systolic blood pressure changes (mmHg) on the vertical axis versus time (hours) on the horizontal axis.*

FDA Label Image

Figure 6 (Sildenafil 6)

A line graph depicting plasma concentration (ng/mL) of a treatment over time (hours) post dose up to 24 hours, comparing a commercial tablet and an unspecified treatment. The graph shows a peak early after dosing with a decline over time for both treatments.*

FDA Label Image

Figure 7 (Sildenafil 7)

Two bar charts showing the effect of SILDENAFIL tablets and placebo on maintenance of erection by baseline score. The x-axis represents baseline scores from 0 to 5, and the y-axis shows the percentage of patients at endpoint. Different bar shades indicate scores from 0 to 5 in the legend. The top chart illustrates sildenafil's effect, with increasing percentages at higher baseline scores. The bottom chart shows varied placebo responses across baseline scores.*

FDA Label Image

Figure 8 (Sildenafil 8)

A bar chart showing the percentage of patients reporting improvement across treatment groups: placebo (24%), and sildenafil tablets at 25 mg (63%), 50 mg (74%), and 100 mg (82%). The x-axis lists the treatment groups and sample sizes; the y-axis shows percentage improvement from 0 to 100%.*

FDA Label Image

Principal Display Panel -1 (Sildenafil 9)

Label for Sildenafil Tablets USP 25 mg oral tablets, containing 30 tablets per container. The label includes storage instructions, manufacturer and distributor details, and displays the Exelan Pharmaceuticals, Inc. logo. The label indicates the product is prescription-only and includes an NDC number and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.